Tested Applications
| Positive WB detected in | mouse heart tissue, human heart tissue, human kidney tissue, rat heart tissue, mouse kidney tissue |
| Positive IHC detected in | human breast cancer tissue, human pancreas cancer tissue, human renal cell carcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | Hela cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:10-1:100 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11289-1-AP targets PARP3 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1844 Product name: Recombinant human PARP3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 234-533 aa of BC014260 Sequence: EALEEALKGPTDGGQSLEELSSHFYTVIPHNFGHSQPPPINSPELLQAKKDMLLVLADIELAQALQAVSEQEKTVEEVPHPLDRDYQLLKCQLQLLDSGAPEYKVIQTYLEQTGSNHRCPTLQHIWKVNQEGEEDRFQAHSKLGNRKLLWHGTNMAVVAAILTSGLRIMPHSGGRVGKGIYFASENSKSAGYVIGMKCGAHHVGYMFLGEVALGREHHINTDNPSLKSPPPGFDSVIARGHTEPDPTQDTELELDGQQVVVPQGQPVPCPEFSSSTFSQSEYLIYQESQCRLRYLLEVHL Predict reactive species |
| Full Name | poly (ADP-ribose) polymerase family, member 3 |
| Calculated Molecular Weight | 60 kDa |
| Observed Molecular Weight | 60-62 kDa |
| GenBank Accession Number | BC014260 |
| Gene Symbol | PARP3 |
| Gene ID (NCBI) | 10039 |
| RRID | AB_2283392 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y6F1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PARP3 (Poly(ADP-ribose) polymerase 3), also known as ARTD3, is the third member of the PARP family that catalyze a post-translational modification of proteins to promote, control or adjust numerous cellular events including genome integrity, transcription, differentiation, cell metabolism or cell death (PMID: 31095444). PARP3 is a 60-kDa protein containing an N-terminal WGR (tryptophan-, glycine-, and arginine-rich) domain and a C-terminal catalytic domain. PARP3 has been described to interact with partners belonging to the NHEJ pathway including DNA-PKcs, DNA ligase IV, Ku70 and Ku80 and to accelerate XRCC4/DNA ligase IV-mediated ligation of chromosomal DSB in concert with APLF (PMID: 24598253).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for PARP3 antibody 11289-1-AP | Download protocol |
| IHC protocol for PARP3 antibody 11289-1-AP | Download protocol |
| WB protocol for PARP3 antibody 11289-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PARP3 Polyclonal antibody (Cat# 11289-1-AP) has 5 citations published in Molecular Cell, EBioMedicine, Cell Chemical Biology, Molecular Medicine, and Cancers (Basel). The associated research fields include chromatin regulation and human disease, PARP inhibitor–induced tumour senescence, allosteric regulation of DNA binding by PARP-1 inhibitors, macrophage inflammation via mono-ADP-ribosylation, and AML progression through PI3K/AKT/mTOR signaling. All citations used the antibody for Western blot in human or mouse samples.
| Species | Application | Title |
|---|---|---|
Mol Cell Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease. | ||
EBioMedicine PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response | ||
Cell Chem Biol Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors
| ||
Cancers (Basel) PARP3 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling.
|

















